Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
暂无分享,去创建一个
Di Yan | John W Wong | D. Yan | F. Vicini | J. Wong | L. Kestin | Alvaro A. Martinez | I. Grills | Frank A Vicini | Inga S Grills | Larry L Kestin | Alvaro A Martinez | Alvaro A. Martinez
[1] Jeffrey D Bradley,et al. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[2] J. Lyman. Complication Probability as Assessed from Dose-Volume Histograms , 1985 .
[3] J. Cooper,et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. , 1982, The Journal of thoracic and cardiovascular surgery.
[4] Joos V Lebesque,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.
[5] W. Curran,et al. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 , 2000 .
[6] E. Noordijk,et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? , 1996, International journal of radiation oncology, biology, physics.
[7] R K Ten Haken,et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.
[8] M. Satouchi,et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[9] W. Curran,et al. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410) , 2000 .
[10] T. Ohno,et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. , 1999, Lung cancer.
[11] P. Blitzer,et al. Radiation therapy in the management of medically inoperable carcinoma of the lung , 1991 .
[12] B. Jeremic,et al. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. , 1997, International journal of radiation oncology, biology, physics.
[13] J. Pignon,et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[15] J A Purdy,et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.
[16] J. Wong,et al. The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.
[17] R L Wahl,et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.
[18] W. Curran,et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. , 2000, International journal of radiation oncology, biology, physics.
[19] T. Weisenburger,et al. Effects of Postoperative Mediastinal Radiation on Completely Resected Stage 11 and Stage Ill Epidermoid Cancer of the Lung * LCSG 773 , 2007 .
[20] J. Bonner,et al. Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer. , 2000, Seminars in radiation oncology.
[21] K. Kayser,et al. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients , 1987, Cancer.
[22] A. Turrisi,et al. Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. , 2000, Seminars in radiation oncology.
[23] J Wong,et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.
[24] R K Ten Haken,et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.
[25] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[26] M. Matthews,et al. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. , 1973, Cancer chemotherapy reports. Part 3.
[27] Joos V Lebesque,et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] P. Thomas,et al. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1990, The Annals of thoracic surgery.
[29] J Wong,et al. Setup error in radiotherapy: on-line correction using electronic kilovoltage and megavoltage radiographs. , 2000, International journal of radiation oncology, biology, physics.
[30] M T Munley,et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.
[31] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. , 1994, Lung cancer.
[32] M. Gail,et al. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. , 1986, The New England journal of medicine.
[33] G J Kutcher,et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.
[34] F. Vicini,et al. Reduction in heart and lung doses using deep inspiration breath hold with active breathing control for patients treated with loco regional breast irradiation including the internal mammary nodes , 2002 .
[35] Di Yan,et al. Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.
[36] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[37] P. Blitzer,et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. , 1992, International journal of radiation oncology, biology, physics.
[38] W. Curran,et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. , 1997, International journal of radiation oncology, biology, physics.
[39] M. Martel,et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.
[40] José Belderbos,et al. Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis , 2003 .
[41] J Wong,et al. The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. , 1998, International journal of radiation oncology, biology, physics.
[42] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[43] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] J Hanson,et al. Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration. , 2001, International journal of radiation oncology, biology, physics.
[45] J C Rosenwald,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.
[46] P. Maguire,et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. , 1999, International journal of radiation oncology, biology, physics.
[47] N. Martini,et al. The role of surgery in N2 lung cancer. , 1987, The Surgical clinics of North America.
[48] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[49] D Yan,et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[50] Michael B Sharpe,et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. , 2003, International journal of radiation oncology, biology, physics.
[51] J C Rosenwald,et al. CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. , 2001, International journal of radiation oncology, biology, physics.
[52] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] M. Goitein,et al. Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.
[54] H. Choy,et al. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. , 1999, Seminars in radiation oncology.
[55] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[56] W. Curran,et al. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. , 1997, Seminars in oncology.
[57] K. Rosenzweig,et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[58] D. Page,et al. Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population , 1987, Journal of surgical oncology.
[59] C B Caldwell,et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.
[60] Y. Tamaki,et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] D A Jaffray,et al. Active breathing control (ABC) for Hodgkin's disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment. , 2000, International journal of radiation oncology, biology, physics.
[62] M. Anscher,et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. , 1998, International journal of radiation oncology, biology, physics.
[63] R. Stephens,et al. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. , 1996, British Journal of Cancer.
[64] M E Burt,et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.